Full text loading...
Brostallicin, a specific adenine-thymine minor groove binder belonging to a new class of distamycin A-derivatives, proved to be active in vitro against a panel of human tumor cell lines. We demonstrated here the cytotoxic and apoptotic potential of this compound on gastric and colon cancer cell lines with either wt or mutated p53.